NCT04262336 - Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 21, 2020

Primary Completion Date

July 30, 2022

Study Completion Date

May 23, 2023

Conditions

Ototoxicity

Interventions

DRUG

DB-020

Injectable sterile viscous solution of DB-020 and sodium hyaluronate in sterile water

DRUG

Placebo

Injectable sterile viscous solution of sodium hyaluronate in sodium chloride

Trial Locations (8)

Peter MacCallum Cancer Centre, Melbourne

Oncology and Palliative Care Research, Melbourne

Queensland Head and Neck Cancer Centre, Woolloongabba

Fiona Stanley Hospital, Clinical Trials Unit Cancer Center, Murdoch

Northwell Health Cancer Center, Lake Success

WVU Cancer Institute, Morgantown

University of Miami Health System, Miami

University of Kansas Medical Center, Kansas City